Microsaic Systems plc (LON:MSYS) has announced the addition of a new technology capability to its platform, as part of the strategic transition from equipment only sales to remote detection and analysis
Microsaic Systems plc (LON:MSYS) has announced the immediate roll-out of its compact Mass Spectrometry technology integrated with autosampler and separation technology, wrapped in closed-loop (automated) control software, for use in
Microsaic Systems plc (LON:MSYS), has noted the update by DeepVerge plc (LON:DVRG) provided today regarding their orders for pathogen monitoring equipment for shipment this year to partners and customers in UK, India and China,
Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry instruments and analytical solutions, has announced its unaudited interim results for the six months ended 30 June 2021. A
Microsaic Systems’ Glenn Tracey discusses the highlights from their final results, what the 12 OEM & distribution agreements mean to the business operationally, the benefits of the MiD ProteinID products and how the new financial year has started in this exclusive interview with DirectorsTalk.
Microsaic Systems plc (LON:MSYS) CEO Glenn Tracey joins DirectorsTalk to discuss full year results. Glenn talks us through the highlights, with 12 OEM and distribution agreements in place what this means
Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry (“MS”) instruments, today announced its audited financial results for the year ended 31 December 2019. The Company’s Annual
Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry instruments, has today announced the appointment of WH Ireland Limited as Joint Broker with immediate effect, alongside N+1Singer
Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry instruments, today announced that it has signed a global integration and joint sales and marketing heads of terms
Microsaic Systems (LON:MSYS), the developer of point of need mass spectrometry (“MS”) instruments, has today confirmed that revenues for the year ending 31 December 2019 have significantly exceeded 2018, and
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
